Connect with us

Business

Curreen Capital Secures 9% Growth in Q3 2025 Investment Strategy

Editorial

Published

on

Curreen Capital Partners reported a strong performance in the third quarter of 2025, achieving a notable 9% increase in fund value. This growth was bolstered by strategic adjustments in their investment portfolio, particularly following the sale of shares in Enhabit in July. The proceeds from this transaction were reinvested into several companies, highlighting Curreen’s proactive approach to navigating market challenges.

During July, Curreen Capital divested its holdings in Enhabit, receiving $7.69 per share. The decision to sell stemmed from concerns about increasing operational headwinds facing the company. Specifically, the Centers for Medicare and Medicaid Services (CMS) proposed deeper cuts to Medicare home health reimbursement rates, which significantly impacted Enhabit’s valuation. Despite Enhabit’s efforts to adapt to the changing landscape, including a successful Hospice business, the outlook was deemed less favorable compared to other investment opportunities.

The funds from the Enhabit sale were allocated strategically, with 2% of the fund directed towards each of Computacenter, Fortrea, and VF Corp, in addition to approximately 1% invested in 4imprint. Each of these investments was selected based on their potential for growth and favorable market positioning.

Strategic Acquisitions and Portfolio Adjustments

Later in the quarter, Curreen Capital reduced its stake in Credit Acceptance, bringing its position down to just over 1% of the fund. The majority of the proceeds from this sale were used to acquire shares in Kontoor, a company known for its well-managed jeans brands, including Wrangler and Lee. Kontoor, which spun off from VF Corp in 2019, has maintained a strong cash flow profile and has recently expanded its portfolio by acquiring the Helly Hansen brand. The purchase of Kontoor shares was executed at a price of $72.54 per share, reflecting Curreen’s confidence in the company’s growth trajectory.

Additionally, Curreen Capital made smaller investments in Thinkific, Pluxee, and GetBusy. The firm acquired shares in Thinkific, a Canadian company specializing in online course creation, for C$1.87 per share. Thinkific is currently undergoing a strategic transition to target larger clients, which may enhance its long-term profitability despite a temporary reduction in customer numbers.

Curreen also increased its investment in GetBusy, which had already become the fund’s largest position. The firm purchased shares at £0.66 each, following positive management forecasts for its SmartVault business. The company’s leadership, including the CFO and CEO, demonstrated their confidence by personally acquiring shares.

Performance Metrics and Future Outlook

As of the end of the third quarter, Curreen Capital’s year-to-date performance stood at 18.53%, while the annualized return since inception reached 11.0%. In comparison, the S&P 500 and MSCI World indices recorded gains of 8.12% and 7.33%, respectively, during the same period. This performance suggests that Curreen’s investment strategy is yielding favorable results, even amidst a fluctuating market environment.

Looking ahead, Curreen Capital remains committed to identifying and capitalizing on opportunities that align with its investment philosophy. The firm encourages open communication with its partners and is eager to engage in discussions about future strategies.

In conclusion, Curreen Capital’s proactive adjustments and strategic investments have positioned it well for continued growth in a challenging market. The decision to pivot from Enhabit to more promising ventures underscores the firm’s commitment to maximizing shareholder value.

Continue Reading

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.